Bridget A. Ross - Feb 27, 2023 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ Val Gertz
Stock symbol
LMAT
Transactions as of
Feb 27, 2023
Transactions value $
-$344,890
Form type
4
Date filed
3/1/2023, 03:40 PM
Previous filing
Dec 13, 2022
Next filing
Mar 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $210K +7K +591.72% $30.00 8.18K Feb 27, 2023 Direct F1
transaction LMAT Common Stock Sale -$345K -7K -85.54% $49.27 1.18K Feb 27, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise -$210K -7K -35% $30.00 13K Feb 27, 2023 Common Stock 7K $30.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $49.03 to $49.78 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3 This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.